Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Denali Therapeutics (DNLI) Prepaid Assets (2017 - 2026)

Denali Therapeutics has reported Prepaid Assets over the past 9 years, most recently at $32.8 million for Q4 2025.

  • Quarterly Prepaid Assets rose 2.1% to $32.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $32.8 million through Dec 2025, up 2.1% year-over-year, with the annual reading at $32.8 million for FY2025, 2.1% up from the prior year.
  • Prepaid Assets was $32.8 million for Q4 2025 at Denali Therapeutics, down from $34.4 million in the prior quarter.
  • Over five years, Prepaid Assets peaked at $60.7 million in Q1 2025 and troughed at $15.1 million in Q3 2021.
  • The 5-year median for Prepaid Assets is $32.6 million (2022), against an average of $32.6 million.
  • Year-over-year, Prepaid Assets soared 184.33% in 2022 and then fell 27.43% in 2023.
  • A 5-year view of Prepaid Assets shows it stood at $30.6 million in 2021, then increased by 17.98% to $36.1 million in 2022, then decreased by 17.94% to $29.6 million in 2023, then grew by 8.37% to $32.1 million in 2024, then grew by 2.1% to $32.8 million in 2025.
  • Per Business Quant, the three most recent readings for DNLI's Prepaid Assets are $32.8 million (Q4 2025), $34.4 million (Q3 2025), and $35.8 million (Q2 2025).